ATXS•benzinga•
Oppenheimer Maintains Outperform on Astria Therapeutics, Lowers Price Target to $25
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 21, 2024 by benzinga